Eduardo Rocon de Lima was born in Vitoria, Brazil (1979). He graduated in Electrical Engineering at Universidade Federal do Espiríto Santo (UFES) in 2001. From 1999 through 2000 he worked as a research associate at Laboratório de Automação Inteligente and successfully held a CNPq scholarship at UFES. Subsequently he moved to Spain to pursue a Ph.D. degree in Industrial Engineering at Universidad Politécnica de Madrid with Prof. A. Barrientos and Prof. J.L. Pons. His Ph.D. thesis (2006), for which he was awarded the Georges Giralt PhD Award (2008), focused on the development of a rehabilitation robotic exoskeleton that provides a means of testing and validating non grounded control strategies for robotic exoskeletons for active upper limb tremor suppression. Dr. Rocon continued his work in tremor suppression and the application of neuroprosthetics and neurorobotics in rehabilitation on a post-doctoral contract from 2006 to 2009. In 2009, Dr. Rocon was awarded with a Ramón y Cajal contract to continue developing his activities (the most competitive and prestigious postdoc contract in Spain). At the age of 30, Dr. Rocon got a tenured researcher position (2010-present) at CSIC. His career has recently been awarded the prestigious Juan Lopez de Peñalver Award of the Spanish Royal Academy of Engineering.

Luis Concha currently works at the Institute of Neurobiology, Universidad Nacional Autónoma de México. He studies tissue microstructure (mainly through diffusion-weighted MRI )and how it is affected in neurological disorders, in animal models as well as in patients.

Billy graduated in biomedicine, and developed his Master and Ph.D. in neurophisiology in Federal University of Rio de Janeiro. He is founder and CEO of Forebrain, developing services to companies like Grupo Boticário, Natura, TV Globo, Santander, among others. He is the former Brazilian Local Chair of the Neuromarketing Science and Business Association (2015-2018), the global association of neuromarketing, and he is also a Professor at ESPM for MBA courses in Marketing and Behavioral Economics and Coordinator Professor of the Master in Consumer Neuroscience, the first Master in this subject in Brazil.

Roberto A. Lotufo obtained the Electronic Engineering Diploma from Instituto Tecnologico de Aeronautica, Brazil, in 1978, the M.Sc. degree from the University of Campinas, UNICAMP, Brazil, in 1981, and the Ph.D. degree from the University of Bristol, U.K., in 1990, in Electrical Engineering. He is a full professor at the School of Electrical and Computer Engineering, University of Campinas (UNICAMP), Brazil, were he has worked for since 1981. His principal interests are in the areas of Image Processing and Analysis, Mathematical Morphology, Image Segmentation and Medical Imaging. He is one of the main architects of two morphological toolboxes: MMach for Khoros, and SDC Morphology Toolbox for MATLAB. Prof. Lotufo has published over 50 refereed international journal and full conference papers. He was the executive director of Inova Unicamp (www.inova.unicamp.br), the agency for innovation at Unicamp, from 2003 to 2013.

Director of the Graeme Clark Institute, and Sir John Eccles Chair of Medicine, Department of Medicine, University of Melbourne. I also direct the Department of Neurology, St. Vincent's Hospital, with both clinical and administrative responsibilities. I spend 1 day weekly in clinical practice. My specific scientific and clinical expertise has created a unique opportunity to take a leadership role in developing translational research to the treatment of intractable epilepsy. My aim has been to develop a basic and translational research program focused on epilepsy and other neurological diseases to drive the development of collaborative clinical research infrastructure that crosses disciplines. My objectives have included the development of new and innovative imaging processes, basic cell biology in epilepsy and the neurophysiology of epilepsy. Over the last 5 years we have made significant inroads into developing therapeutic electrical stimulation strategies for the treatment of epilepsy, of proven effect in animal models and now being explored in humans. In addition, large groups of physical scientists have been brought into human and animal research, and further developing these links is a key aim. This has been achieved not only through the main work of my laboratory but also through increased collaboration with other University of Melbourne based research groups, supported by Australian Research Council (ARC) and National and Health Medical Research Council (NHMRC) funding. Insights and therapies developed through my research have been translated into practice now, and by utilizing a diverse group of collaborators to enhance the translation of developing research outcomes into health practice, leveraging existing but isolated national resources to create an internationally competitive, clinically- focused research infrastructure.